The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
MPN Advances Day 2019 | Objectively measuring responses in MPNs
Nauman Butt
• 15 Nov 2019
Nauman Butt, MB BCh, MRCP, MD, FRCPath, Royal Liverpool and Broadgreen University Hospital NHS Trust, Liverpool, UK, outlines the everyday clinical challenges for the management of myeloproliferative neoplasms (MPNs), with a focus on objectively measuring patient response. This interview took place at the Myeloproliferative Neoplasms Conference 2019 in London, UK.
